The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training, and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy ...
Nov 12, 2025
0
13
A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors, according to new clinical trial data presented at the ...
Oct 21, 2025
0
24
Post-therapy imaging and dosimetry significantly enhance patient management, empowering clinicians to make more informed, personalized decisions in radiopharmaceutical therapy. A series of case studies presented at the Society ...
Jun 23, 2025
0
11
Radiotherapy is a cornerstone of cancer care. However, in recent decades, Sweden has fallen behind in this area, both in terms of health care resources and research. Medicinsk Vetenskap has interviewed researchers who want ...
Jan 15, 2025
0
23
Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term ...
Dec 11, 2024
0
19
A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, ...
Sep 29, 2024
0
31
A novel approach for early cancer treatment known as radioligand therapy (RLT) has been shown to significantly reduce the risk of advanced neuroendocrine tumor progression and death, according to research led by scientists ...
Jul 2, 2024
0
101
Only one in 100,000 people suffer from a pheochromocytoma, a tumor of the adrenal gland. If the tumor has already metastasized, a radioactive compound can be used to detect malignant cells that have spread to other parts ...
Feb 9, 2023
0
59
